1. LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness
- Author
-
Kevin Christopher Knower, Elena A Takano, Alexander Dobrovic, Stephen B. Fox, Kylie L. Gorringe, Ramyar Molania, David J Byrne, Sandra A O'Toole, Ewan K.A. Millar, Ashwini L. Chand, Jia Min B. Pang, Colin Clyne, Cheok Soon Lee, and Thomas Mikeska
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,estrogen signalling ,NR5A2 ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Gene expression ,Medicine ,breast carcinoma ,Aromatase ,DNA methylation ,biology ,business.industry ,Liver receptor homolog-1 ,Ductal carcinoma ,medicine.disease ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,immunohistochemistry ,Cancer research ,biology.protein ,Immunohistochemistry ,Breast carcinoma ,business ,Research Paper - Abstract
The significance and regulation of liver receptor homologue 1 (LRH-1, NR5A2), a tumour-promoting transcription factor in breast cancer cell lines, is unknown in clinical breast cancers. This study aims to determine LRH-1/NR5A2 expression in breast cancers and relationship with DNA methylation and tumour characteristics. In The Cancer Genome Atlas breast cancer cohort NR5A2 expression was positively associated with intragenic CpG island methylation (1.4-fold expression for fully methylated versus not fully methylated, p=0.01) and inversely associated with promoter CpG island methylation (0.6-fold expression for fully methylated versus not fully methylated, p=0.036). LRH-1 immunohistochemistry of 329 invasive carcinomas and ductal carcinoma in situ (DCIS) was performed. Densely punctate/coarsely granular nuclear reactivity was significantly associated with high tumour grade (p
- Published
- 2017
- Full Text
- View/download PDF